Acs Medicinal Chemistry Letters SCIE

国际简称：ACS Med. Chem. Lett. 参考译名：Acs 药物化学快报

主要研究方向：CHEMISTRY, MEDICINAL 非预警期刊审稿周期：一般,3-8周

《Acs 药物化学快报》(Acs Medicinal Chemistry Letters)是一本由American Chemical Society出版的以CHEMISTRY, MEDICINAL为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
216 年发文量
3.5 IF影响因子
开放是否OA
52 H-index
2010 创刊年份
Monthly 出版周期
English 出版语言

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:

Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)

Biological characterization of new molecular entities in the context of drug discovery

Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.

Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry

Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources

Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response

Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic

Mechanistic drug metabolism and regulation of metabolic enzyme gene expression

Chemistry patents relevant to the medicinal chemistry field.

[ 查看全部 ]

投稿咨询加急咨询

Acs Medicinal Chemistry Letters期刊信息

ISSN：1948-5875
出版语言：English
是否OA：开放
出版地区：UNITED STATES
是否预警：否
出版商：American Chemical Society
出版周期：Monthly
创刊时间：2010
开源占比：0.1324
Gold OA文章占比：16.64%
OA被引用占比：0.0295...
出版国人文章占比：0.09
出版撤稿占比：0
研究类文章占比：100.00%

Acs Medicinal Chemistry Letters CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

7.3

0.883

0.816

学科类别	分区	排名	百分位
大类：Chemistry 小类：Organic Chemistry	Q1	43 / 211	79%
大类：Chemistry 小类：Drug Discovery	Q2	45 / 157	71%
大类：Chemistry 小类：Biochemistry	Q2	134 / 438	69%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Acs Medicinal Chemistry Letters中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CHEMISTRY, MEDICINAL 药物化学	3区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CHEMISTRY, MEDICINAL 药物化学	3区

中科院 2021年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CHEMISTRY, MEDICINAL 药物化学	2区

中科院 2021年12月基础版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CHEMISTRY, MEDICINAL 药物化学	3区

中科院 2021年12月升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	CHEMISTRY, MEDICINAL 药物化学	2区

中科院 2020年12月旧的升级版

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	2区	CHEMISTRY, MEDICINAL 药物化学	2区

Acs Medicinal Chemistry Letters JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CHEMISTRY, MEDICINAL	SCIE	Q2	32 / 72	56.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CHEMISTRY, MEDICINAL	SCIE	Q2	21 / 72	71.53%

Acs Medicinal Chemistry Letters历年数据统计

影响因子

中科院分区

Acs Medicinal Chemistry Letters中国学者发文选摘

1、Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue
Author: Song, Jun; Pan, Chuqiao; Li, Jinxiu; Bai, Ruisong; Zeng, Ziying; Han, Yunying; Chen, Zhao; Hou, Wei; Li, Yong; Ruan, Benfang Helen

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. 14, Issue 1, pp. 11-17. DOI: 10.1021/acsmedchemlett.2c00302
2、Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors
Author: Liu, Meiying; Zhou, Guizhen; Su, Wenhong; Gu, Yuejiao; Gao, Mingshan; Wang, Kun; Huo, Ruifeng; Li, Yupeng; Zhou, Zehui; Chen, Kaixian; Zheng, Mingyue; Zhang, Sulin; Xu, Tianfeng

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00490
3、Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors
Author: Liu, Meiying; Zhou, Guizhen; Su, Wenhong; Gu, Yuejiao; Gao, Mingshan; Wang, Kun; Huo, Ruifeng; Li, Yupeng; Zhou, Zehui; Chen, Kaixian; Zheng, Mingyue; Zhang, Sulin; Xu, Tianfeng

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. 183-190. DOI: 10.1021/acsmedchemlett.2c00490183
4、Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design
Author: Yu, Yang; Huang, Junhong; He, Hu; Han, Jing; Ye, Geyan; Xu, Tingyang; Sun, Xianqiang; Chen, Xiumei; Ren, Xiaoming; Li, Chunlai; Li, Huijuan; Huang, Wei; Liu, Yangyang; Wang, Xinjuan; Gao, Yongzhi; Cheng, Nianhe; Guo, Na; Chen, Xibo; Feng, Jianxia; Hua, Yuxia; Liu, Chong; Zhu, Guoyun; Xie, Zhi; Yao, Lili; Zhong, Wenge; Chen, Xinde; Liu, Wei; Li, Hailong

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00515
5、Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong In Vivo Anticancer Activity
Author: Hou, Wei; Chen, Zhao; Pan, Chuqiao; Ni, Maowei; Ruan, Haoqiang; Song, Jun; Lu, Shiying; Bhasin, Aman; Ruan, Benfang Helen

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00470
6、Development and Characterization of Fluorescent Probes for the G Protein-Coupled Receptor 35
Author: Wei, Lai; Xiang, Kaijing; Kang, Hongjian; Yu, Yancheng; Fan, Hongjie; Zhou, Han; Hou, Tao; Ge, Yonglin; Wang, Jixia; Guo, Zhimou; Chen, Yang; Zhao, Yaopeng; Liang, Xinmiao

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00461
7、Development of the Inverse Sonogashira Reaction for DEL Synthesis
Author: Luo, Ayun; Zhou, Hongxia; Hua, Qini; An, Yufang; Ma, Hangke; Zhao, Xue; Yang, Kexin; Hu, Yun Jin

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00477
8、Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist
Author: Dickson, Louise; Teall, Martin; Chevalier, Elodie; Cheung, Toni; Liwicki, Gemma M.; Mack, Stephen; Stephenson, Anne; White, Kathryn; Fosbeary, Richard; Harrison, David C.; Brice, Nicola L.; Doyle, Kevin; Ciccocioppo, Roberto; Wu, Chaobo; Almond, Sarah; Patel, Toshal R.; Mitchell, Philip; Barnes, Matt; Ayscough, Andrew P.; Dawson, Lee A.; Carlton, Mark; Burli, Roland W.

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00529